Stada Arzneimittel Q2 Net Profit Up 9%

Loading...
Loading...
Stada Arzneimittel AG
STDAF
reported a 9% rise in its second-quarter net profit. Stada Arzneimittel's quarterly sales climbed to EUR441.9 million ($547.7 million), versus EUR411.4 million, in the year-ago period. However, analysts were expecting revenue of EUR447 million. Its net profit climbed to EUR28.7 million, versus analysts' estimates of EUR31 million. Stada Arzneimittel's sales in the Asia-Pacific region jumped 54% y/y to EUR33.2 million in the first half, while sales in western Europe gained 3% to EUR595.5 million.
Posted In: EarningsNewsprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...